Abstracts tagged "anti-CCP antibodies and Early Rheumatoid Arthritis"

Abstract Number: 495 • ACR/ARP Annual Meeting 2019
Pre-Rheumatoid Arthritis Diagnosis Prevalence of Commercial CCP Antibody Positivity Increases over Time with Strong Agreement Between Commercial Assays and Positivity Is Predicative of Developing Rheumatoid Arthritis Within 3 Years
Steven Taylor¹, Mark Parish ², LauraKay Moss ³, Marie Feser ⁴, Elizabeth Mewshaw ⁵, Jess Edison ⁵ and Kevin Deane ⁴, ¹University of Colorado - Denver, Denver, CO, ²University of Colorado Denver, Aurora, CO, ³University of Colorado Denver, Division of Rheumatology, Aurora, CO USA, Aurora, CO, ⁴University of Colorado Denver, Division of Rheumatology, Aurora, CO, USA, Aurora, CO, ⁵Walter Reed National Military Medical Center, Bethesda, MD
Background/Purpose: Rheumatoid arthritis (RA) related autoantibodies, in particular antibodies to citrullinated proteins (ACPA), predict likelihood of developing future RA. Indeed, clinical trials for RA prevention…